Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17

Background: The Tau58/2 and Tau58/4 mouse lines expressing 0N4R tau with a P301S mutation mimic aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). In a side-by-side comparison, we report the age-dependent development of cognitive, motor, and behavioral deficits in...

Full description

Bibliographic Details
Main Authors: Debby Van Dam, Femke Valkenburg, Kristof Van Kolen, Isabel Pintelon, Jean-Pierre Timmermans, Peter Paul De Deyn
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/10/2088
_version_ 1797573224678031360
author Debby Van Dam
Femke Valkenburg
Kristof Van Kolen
Isabel Pintelon
Jean-Pierre Timmermans
Peter Paul De Deyn
author_facet Debby Van Dam
Femke Valkenburg
Kristof Van Kolen
Isabel Pintelon
Jean-Pierre Timmermans
Peter Paul De Deyn
author_sort Debby Van Dam
collection DOAJ
description Background: The Tau58/2 and Tau58/4 mouse lines expressing 0N4R tau with a P301S mutation mimic aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). In a side-by-side comparison, we report the age-dependent development of cognitive, motor, and behavioral deficits in comparison with the spatial-temporal evolution of cellular tau pathology in both models. Methods: We applied the SHIRPA primary screen and specific neuromotor, behavioral, and cognitive paradigms. The spatiotemporal development of tau pathology was investigated immunohistochemically. Levels of sarkosyl-insoluble paired helical filaments were determined via a MesoScale Discovery biomarker assay. Results: Neuromotor impairments developed from age 3 months in both models. On electron microscopy, spinal cord neurofibrillary pathology was visible in mice aged 3 months; however, AT8 immunoreactivity was not yet observed in Tau58/4 mice. Behavioral abnormalities and memory deficits occurred at a later stage (>9 months) when tau pathology was fully disseminated throughout the brain. Spatiotemporally, tau pathology spread from the spinal cord via the midbrain to the frontal cortex, while the hippocampus was relatively spared, thus explaining the late onset of cognitive deficits. Conclusions: Our findings indicate the face and construct validity of both Tau58 models, which may provide new, valuable insights into the pathologic effects of tau species in vivo and may consequently facilitate the development of new therapeutic targets to delay or halt neurodegenerative processes occurring in tauopathies.
first_indexed 2024-03-10T21:06:54Z
format Article
id doaj.art-6c1945a425ec48379ee799912401d6bb
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T21:06:54Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-6c1945a425ec48379ee799912401d6bb2023-11-19T17:07:14ZengMDPI AGLife2075-17292023-10-011310208810.3390/life13102088Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17Debby Van Dam0Femke Valkenburg1Kristof Van Kolen2Isabel Pintelon3Jean-Pierre Timmermans4Peter Paul De Deyn5Laboratory of Neurochemistry and Behavior, Experimental Neurobiology Unit, University of Antwerp, Wilrijk, 2610 Antwerp, BelgiumLaboratory of Neurochemistry and Behavior, Experimental Neurobiology Unit, University of Antwerp, Wilrijk, 2610 Antwerp, BelgiumNeuroscience Department, Janssen Research and Development, 2340 Beerse, BelgiumLaboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, 2610 Antwerp, BelgiumLaboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, 2610 Antwerp, BelgiumLaboratory of Neurochemistry and Behavior, Experimental Neurobiology Unit, University of Antwerp, Wilrijk, 2610 Antwerp, BelgiumBackground: The Tau58/2 and Tau58/4 mouse lines expressing 0N4R tau with a P301S mutation mimic aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). In a side-by-side comparison, we report the age-dependent development of cognitive, motor, and behavioral deficits in comparison with the spatial-temporal evolution of cellular tau pathology in both models. Methods: We applied the SHIRPA primary screen and specific neuromotor, behavioral, and cognitive paradigms. The spatiotemporal development of tau pathology was investigated immunohistochemically. Levels of sarkosyl-insoluble paired helical filaments were determined via a MesoScale Discovery biomarker assay. Results: Neuromotor impairments developed from age 3 months in both models. On electron microscopy, spinal cord neurofibrillary pathology was visible in mice aged 3 months; however, AT8 immunoreactivity was not yet observed in Tau58/4 mice. Behavioral abnormalities and memory deficits occurred at a later stage (>9 months) when tau pathology was fully disseminated throughout the brain. Spatiotemporally, tau pathology spread from the spinal cord via the midbrain to the frontal cortex, while the hippocampus was relatively spared, thus explaining the late onset of cognitive deficits. Conclusions: Our findings indicate the face and construct validity of both Tau58 models, which may provide new, valuable insights into the pathologic effects of tau species in vivo and may consequently facilitate the development of new therapeutic targets to delay or halt neurodegenerative processes occurring in tauopathies.https://www.mdpi.com/2075-1729/13/10/2088tauopathyfrontotemporal dementiaAlzheimer’s diseasemotor dysfunctioncognitive deficitsbehavioral disinhibition
spellingShingle Debby Van Dam
Femke Valkenburg
Kristof Van Kolen
Isabel Pintelon
Jean-Pierre Timmermans
Peter Paul De Deyn
Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
Life
tauopathy
frontotemporal dementia
Alzheimer’s disease
motor dysfunction
cognitive deficits
behavioral disinhibition
title Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
title_full Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
title_fullStr Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
title_full_unstemmed Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
title_short Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
title_sort behavioral and neuropathological phenotyping of the tau58 2 and tau58 4 transgenic mouse models for ftdp 17
topic tauopathy
frontotemporal dementia
Alzheimer’s disease
motor dysfunction
cognitive deficits
behavioral disinhibition
url https://www.mdpi.com/2075-1729/13/10/2088
work_keys_str_mv AT debbyvandam behavioralandneuropathologicalphenotypingofthetau582andtau584transgenicmousemodelsforftdp17
AT femkevalkenburg behavioralandneuropathologicalphenotypingofthetau582andtau584transgenicmousemodelsforftdp17
AT kristofvankolen behavioralandneuropathologicalphenotypingofthetau582andtau584transgenicmousemodelsforftdp17
AT isabelpintelon behavioralandneuropathologicalphenotypingofthetau582andtau584transgenicmousemodelsforftdp17
AT jeanpierretimmermans behavioralandneuropathologicalphenotypingofthetau582andtau584transgenicmousemodelsforftdp17
AT peterpauldedeyn behavioralandneuropathologicalphenotypingofthetau582andtau584transgenicmousemodelsforftdp17